Indian Contract Manufacturing - A Hot Opportunity

Published Date: Mar 08                                                                                       No of Pages: 70
Format: Single User PDF

“Indian Contract Manufacturing - A Hot Opportunity” is the recent report by RNCOS that gives first hand information on the thriving contract manufacturing market in India and the opportunities it is opening up for global players. 

The Indian contract manufacturing market was worth US$ 874 Million in 2007. Although this market presently occupies a fraction of the total global opportunity, the future potential of the market seems immense. The Indian contract manufacturing market, with its low cost advantage, strong chemistry and reverse engineering capabilities, improving infrastructure and strong incentives from the government, is expected to grow strongly in the next five years. By 2012, the Indian industry is expected to grab nearly 8% of the total global market.

The report comprehensively evaluates the contract manufacturing market in India, analyzing its present market size, key segments, capabilities, and the future direction of growth. It also gives a statistical and analytical insight into the various factors vital for drug manufacturing, such as the competitive advantage/disadvantage of India vis-à-vis developed countries on various parameters such as cost, infrastructure, intellectual property and infrastructure etc.
 

• Indian contract manufacturing market is expected to grow in excess of CAGR 37% between 2007 and 2012.
• Most companies presently outsource APIs and intermediates from India. Moreover, India is also becoming a major hub for outsourcing formulations.
• Many Indian manufacturers have upgraded their manufacturing plants, which has enabled India to have a number of plants certified by the FDA, EDQM and various other regulatory agencies.
• The cost of secondary manufacturing in India is around 13%-15% of the cost in the US, the UK and Germany, with companies making substantial savings on costs of plant set up, labor and operations.
• India has more than four times the total drug manufacturing staff than the US and more than 12 times that in the UK.
• Growth of the contract manufacturing market is expected to provide a major boost to the pharma machinery market in India, which is expected to register revenues up to US$ 822 Million by 2010.
• Strong appreciation of the Indian Rupee against the US Dollar is having a detrimental effect on the profits of many Indian contract manufacturers.

• Evaluation of the total size and growth rate of the contract manufacturing market.
• Analysis of key segments.
• Evaluation of India’s capability in pharmaceutical manufacturing.
• Analysis of the total costs incurred while manufacturing a drug in India (such as cost of land, construction, labor, utilities, freight etc).
• Analysis of the country’s pharma-related human resources.
• Study of the country’s pharma-related infrastructure.
• Analysis of the key opportunities created by the industry.
• Analysis of key players, including their business overview, key facts, and financial information.

 
1. Analyst View
2. Global Contract Manufacturing Market
     2.1 Rising Trend of Outsourcing
     2.2 Market Analysis
            2.2.1 Market Size
                      2.2.1.1 Chemical Synthesis
                      2.2.1.2 Formulations & Packaging
3. India - Most Potential Contract Manufacturing Destination
     3.1 Pharma Outsourcing Market
            3.1.1 Contract Manufacturing Market
                      3.1.1.1 Chemical Synthesis
                      3.1.1.2 Formulation & Packaging
     3.2 Manufacturing Analysis
            3.2.1 Bulk Drugs
            3.2.2 Formulations
            3.2.3 Drug Packaging
            3.2.4 Biopharmaceuticals
     3.3 Cost Analysis
            3.3.1 Employment Cost
            3.3.2 Office Rental Cost
            3.3.3 Industrial Land Rental Cost
            3.3.4 Construction Cost
            3.3.5 Cost of Utilities
            3.3.6 Freight Cost
     3.4 Analysis of Human Resources
            3.4.1 Pharma Personnel
            3.4.2 Pharma-related Degrees
     3.5 Infrastructure Analysis
            3.5.1 Manufacturing
            3.5.2 Logistics
            3.5.3 ICT
            3.5.4 Energy Capacity & Production
4. Industry Analysis
     4.1 Market Drivers
            4.1.1 Increasing Prevalence of Generics
            4.1.2 Cost Advantage
            4.1.3 Well-developed Infrastructure
            4.1.4 Improved IPR Laws
            4.1.5 Emerging Pharmaceutical Market
            4.1.6 Huge Pool of Human Resources
     4.2 Opportunities
            4.2.1 Supplementary Services in Pharma Outsourcing
            4.2.2 Third Party Logistics Market
            4.2.3 Pharma Machinery Market
            4.2.4 Real Estate Market
     4.3 Challenges & Threats
            4.3.1 Counterfeit Drugs
            4.3.2 High Wage Inflation & Attrition
            4.3.3 Currency Appreciation
            4.3.4 Threats from China
5. Key Players
     5.1 Divis Laboratories Limited
     5.2 Dr. Reddy's Laboratories Limited
     5.3 Nicholas Piramal India Limited
     5.4 Jubilant Organosys Healthcare Limited
     5.5 Shasun Chemicals and Drugs Limited
     5.6 Dishman Pharmaceuticals & Chemicals Limited

How to buy this report

Kindly note that the online payment gateway does not work at present - we regret the same. This report can be obtained by sending a Demand Draft in favour of Milagrow Business and Knowledge Solutions Pvt Ltd, payable at Gurgaon, with a cover note mentioning the report title, SKU number, your complete address, email id and telephone numbers. The report would be mailed to your id at the earliest.  The amount payable is indicated at the start of this page.

Kindly mail the Demand Draft and the cover note to the Knowledge Solutions Department, Milagrow Business & Knowledge Solutions, 796, Udyog Vihar, Phase V, Gurgaon, 122016.